Comparison · NCT01912716-3dd52c8f
Standard Dose 100 mg vs High Dose 200mg: Number of Participants With Moderate or Severe Post-ERCP Pancreatitis
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Standard Dose 100 mg vs High Dose 200mg: Number of Participants With Moderate or Severe Post-ERCP Pancreatitis. Trial comparisons, record NCT01912716-3dd52c8f. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01912716-3dd52c8f
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0544 | 0.0379 | 0.0775 | wilson | |
| Risk in group 2 | 0.0536 | 0.0374 | 0.0764 | wilson | |
| Risk difference, group 1 minus group 2 | 0.000729 | -0.0274 | 0.029 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.01 | 0.609 | 1.69 | log | |
| Odds ratio, group 1 over group 2 | 1.01 | 0.592 | 1.74 | log | |
| Number needed to treat, for one more participant with the outcome on Standard Dose 100 mg than on High Dose 200mg | 1,370 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Standard Dose 100 mg | patients receiving 100mg indomethacin | 28 | 515 | OG000 |
| Group 2 | High Dose 200mg | patients receiving 200mg indomethacin | 28 | 522 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Moderate or Severe Post-ERCP Pancreatitis
- Description
Assessment of whether patients developed either moderate or severe post-ERCP pancreatitis, defined according to established consensus criteria (Cotton et al., Gastrointestinal Endoscopy 1991;37:383-93). Severity of post-ERCP pancreatitis is partly defined according to length of stay. Moderate pancreatitis is defined as a 4-10 day hospitalization. Severe post-ERCP pancreatitis is defined as a hospitalization of greater than 10 days post-ERCP, or development of a complication (eg. pseudocyst or necrosis), or need for intervention (drainage or surgery).
- Time frame
- 30 days
- Population
- development of moderate or severe post-ERCP pancreatitis
Source ClinicalTrials.gov
Trial
- Title
- Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis
- NCT number
- NCT01912716
- Phases
- PHASE2, PHASE3
- Conditions
- Post-ERCP Pancreatitis
- Interventions
- high dose indomethacin, standard dose indomethacin
- Lead sponsor
- Indiana University
- Results first posted
- 2019-06-18
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01912716?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01912716-3dd52c8f